Annandale Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.14M Sell
21,017
-1,123
-5% -$262K 0.72% 38
2025
Q4
$4.58M Sell
22,140
-31
-0.1% -$6.13K 0.54% 46
2025
Q3
$41.1M Hold
22,171
0.7% 44
2025
Q2
$3.39M Buy
22,171
+1,000
+5% +$154K 0.26% 51
2025
Q1
$3.51M Sell
21,171
-51
-0.2% -$7.98K 0.22% 59
2024
Q4
$3.07M Buy
21,222
+26
+0.1% +$4.03K 0.49% 54
2024
Q3
$3.44M Hold
21,196
0.48% 45
2024
Q2
$3.1M Hold
21,196
0.53% 48
2024
Q1
$3.35M Hold
21,196
0.62% 43
2023
Q4
$3.32M Buy
21,196
+2,025
+11% +$311K 0.63% 45
2023
Q3
$2.99M Buy
19,171
+1,221
+7% +$201K 0.74% 40
2023
Q2
$2.97M Sell
17,950
-75
-0.4% -$12.1K 0.86% 36
2023
Q1
$2.79M Buy
18,025
+5
+0% +$807 0.88% 32
2022
Q4
$3.18M Hold
18,020
1.05% 28
2022
Q3
$2.94M Sell
18,020
-2
-0% -$338 1.09% 26
2022
Q2
$3.2M Sell
18,022
-456
-2% -$81.2K 1.27% 25
2022
Q1
$3.27M Sell
18,478
-679
-4% -$116K 1.29% 25
2021
Q4
$3.28M Hold
19,157
1.44% 23
2021
Q3
$3.09M Sell
19,157
-2,446
-11% -$417K 1.86% 17
2021
Q2
$3.56M Buy
21,603
+213
+1% +$35.3K 2.14% 16
2021
Q1
$3.52M Sell
21,390
-28
-0.1% -$4.53K 2.49% 16
2020
Q4
$3.37M Buy
+21,418
New +$3.16M 2.82% 14

Other funds holding JNJ

Annandale Capital's JNJ Position: Q1 2026 in Review

Annandale Capital reduced its Johnson & Johnson (JNJ) stake by 5.1% in Q1 2026, selling an estimated $262K and leaving 21,017 shares worth $5.14M. The position accounts for 0.72% of the portfolio, ranked #38.

Annandale Capital first reported a position in JNJ in Q4 2020 and has held it in 22 quarters since. The position peaked at $41.1M in Q3 2025. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Annandale Capital held 21,017 shares of Johnson & Johnson worth $5.14M as of Q1 2026.
  • Annandale Capital sold 1,123 Johnson & Johnson shares in Q1 2026, an estimated $262K.
  • Johnson & Johnson made up 0.72% of Annandale Capital's portfolio in Q1 2026, its #38 holding.
  • Annandale Capital first reported a position in Johnson & Johnson in Q4 2020 and has held it in 22 quarters since.
  • Annandale Capital's Johnson & Johnson position peaked at $41.1M in Q3 2025.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Annandale Capital's 13F filing for Q1 2026, filed 15 May 2026.